True the xoma trial was uncontrolled - but the condition was not prone to "spontaneous recovery" or placebo effects - you either see well or you have constrained vision. It was pretty clear the results showed efficacy. The questions that remain are toxicity, duration of response, etc. and indications beyond bechets U
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.